2-((4-hydroxy-3-methoxyphenyl)(5-(4-hydroxy-3-methoxyphenyl)-4-(hydroxymethyl)tetrahydrofuran-3-yl)methoxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol

Catalog No. :
ACMDMA277
CAS No. :
131653-21-9
Molecular Formula :
C26H34O12
Molecular Weight :
538.55

IUPAC Name:2-((4-hydroxy-3-methoxyphenyl)(5-(4-hydroxy-3-methoxyphenyl)-4-(hydroxymethyl)tetrahydrofuran-3-yl)methoxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol

2-((4-hydroxy-3-methoxyphenyl)(5-(4-hydroxy-3-methoxyphenyl)-4-(hydroxymethyl)tetrahydrofuran-3-yl)methoxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((4-hydroxy-3-methoxyphenyl)(5-(4-hydroxy-3-methoxyphenyl)-4-(hydroxymethyl)tetrahydrofuran-3-yl)methoxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
IUPAC Name2-((4-hydroxy-3-methoxyphenyl)(5-(4-hydroxy-3-methoxyphenyl)-4-(hydroxymethyl)tetrahydrofuran-3-yl)methoxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
Molecular FormulaC26H34O12
Molecular Weight538.55
SMILESCOC1=C(O)C=CC(C2OCC(C(OC3OC(CO)C(O)C(O)C3O)C3=CC(OC)=C(O)C=C3)C2CO)=C1
InChI KeyWMABCPOXSNGIJO-UHFFFAOYSA-N
Synonymβ-D-Glucopyranoside, (S)-(4-hydroxy-3-methoxyphenyl)[(3S,4R,5S)-tetrahydro-5-(4-hydroxy-3-methoxyphenyl)-4-(hydroxymethyl)-3-furanyl]methyl;Tanegoside
CAS No.131653-21-9

Synthetic Route by SureRoute

1. ACMDMA277 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMDMA277 route product structure diagram
    ACMDMA277131653-21-9
Inquiry

2. ACMDMA277 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMDMA277 route product structure diagram
    ACMDMA277131653-21-9
Inquiry

Comments (0)